JCU vs Notre Dame Fremantle

JCU uses no admission test. Notre Dame Fremantle uses GAMSAT and CASPer. The test mismatch means you may need to prep two assessments simultaneously, or you can pick the school whose admission test you're stronger in. GAMSAT is graduate-only and sat in March/September; UCAT-ANZ is undergraduate-leaning and sat in July; some schools (notably Bond and JCU) run their own selection model with no national test.

JCU — does not publish a GAMSAT cut-off (may not use GAMSAT; check the admission-test question above). Notre Dame Fremantle — Minimum 52 overall + 50 in each subsection (UNDA averages the three sections rather than using the overall weighted GAMSAT). 2023 intake average successful GAMSAT 66 (3-year avg ~60+). GAMSAT results are valid for four years with ACER, but some graduate MD programs accept only the most recent two cycles — verify before relying on an older sitting.

JCU — 2024 intake: ATAR floor 89.4; Cairns median 97.95; Townsville median 97.60. Non-Year-12 GPA floor 5.75. Written application carries dominant weight over ATAR. Notre Dame Fremantle — ATAR data not published in the structured AU requirements; see free-text admission requirements on the school page. Selection rank typically includes Educational Access Scheme bonuses, rural-origin uplift, and (where applicable) Indigenous-pathway adjustments — your raw ATAR is rarely the final figure used.

JCU — GPA not published in the structured AU requirements. Notre Dame Fremantle — Minimum 5.2/7.0. 2023 intake average successful GPA 6.70 (3-year avg ~6.7); competitive ≥6.3. Many AU graduate MD programs treat the GPA as a hurdle (above the floor, all candidates are weighted equally on GAMSAT and interview) rather than as a sliding-scale rank — confirm each school's specific model.

JCU uses: Kira Talent one-way recorded interview (online, ~30-60 min). Notre Dame Fremantle uses: MMI (asynchronous online via Modern Hire). Different formats reward different skill sets. Plan separate prep streams for each. Interview windows: November-January (Kira Talent windows: 25 Nov-2 Dec 2025, plus 2 & 5 Jan 2026 for 2026 entry) (JCU); September-November (Notre Dame Fremantle).

JCU — Approximately 150 CSP for domestic students + ~40 international. Mix of CSP, BMP, and Rural Access Scheme. Notre Dame Fremantle — 2027 cycle: 80 CSP (60 Fremantle + 20 KCRMT Broome pathway) + 32 BMP (Fremantle only) + up to 15 International (Fremantle only) + uncapped Indigenous (from 1 Jan 2026) ≈ ~127 total (up from 110 in 2026, +17 places). CSP (Commonwealth Supported Place) is the lowest student contribution; BMP (Bonded Medical Program) adds a 1-year return-of-service obligation in a Modified Monash Model 2-7 area after Fellowship; Full-fee places carry no bond but the highest tuition.

JCU — Indigenous Selection Pathway. ACCHO partnerships referenced via the JCU Centre for Rural & Remote Health: Apunipima Cape York Health Council, Gidgee Healing (Mt Isa / North-West QLD), Nukal Murra Alliance, Wuchopperen Health Service (Cairns). Notre Dame Fremantle — Uncapped Indigenous CSP allocation from 1 January 2026 (Commonwealth policy change). Bespoke Aboriginal and Torres Strait Islander entry pathway. Both schools accept ATSI applicants through the standard pathway as well; the dedicated pathway typically offers adjusted academic thresholds plus wrap-around academic support.

JCU — JCU uses the federal Bonded Medical Program (BMP) + Rural Access Scheme for ~80% of CSP intake. MRBS is a closed legacy scheme nationally (replaced by BMP from 2020). Mid-career graduate outcomes (PGY5-14, 2019 cohort of 931 graduates): 54.0% MMM1 metro, 29.1% MMM2 regional cities, 14.1% MMM3-5 rural towns, 2.9% MMM6-7 remote. >57% of cohort at admission from North QLD; 74% from non-metropolitan areas. Notre Dame Fremantle — 32 BMP places (Fremantle only) + 20 CSP at KCRMT Broome from 2027 (Kimberley-region remote-workforce expansion). Bonus points (10% of interview shortlist) awarded for rurality, WA residency, and higher degrees research completion. The federal BMP allocates ~28.5% of CSP places nationally; individual schools sit above or below that benchmark depending on their workforce remit.

JCU typically releases medicine offers Rolling — August through January. Notre Dame Fremantle releases medicine offers November-December. AU MD offers run through GEMSAS (graduate consortium) or direct school portals; if one is earlier than the other you may need to defer a decision while waiting for the second.

JCU runs a Integrated curriculum. Notre Dame Fremantle runs a Integrated curriculum. Both schools deliver teaching in the same broad style, so day-to-day study habits will feel similar. JCU specifics: 6-year undergraduate MBBS (BMBS). Years 1-2 foundations at Townsville (Douglas) campus. Years 3-4 clinical introductions and rural/remote placements. Years 5-6 distributed clinical placements across T Notre Dame Fremantle specifics: 4-year graduate MD. Years 1-2 foundations and clinical skills at Fremantle with early clinical immersion. Years 3-4 hospital and rural placements across St John of God Fremantle, Joondalup, Rockingham

Yes — AU medical applicants typically lodge preferences across multiple schools via GEMSAS (graduate) or direct-undergraduate portals + state TACs (UAC for NSW, VTAC for VIC, QTAC for QLD, etc.). The two schools' selection mechanics differ enough that listing both is a legitimate diversification strategy. A common mistake is over-indexing on schools with the same test-and-interview profile; JCU and Notre Dame Fremantle differ in their selection mechanics, so prepping both adds genuine optionality.